Neuronal life-and-death signaling, apoptosis, and neurodegenerative disorders

被引:163
作者
Mattson, Mark P. [1 ]
机构
[1] NIA, Intramural Res Program, Baltimore, MD 21224 USA
关键词
D O I
10.1089/ars.2006.8.1997
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
When subjected to excessive oxidative stress, neurons may respond adaptively to overcome the stress, or they may activate a programmed cell death pathway called apoptosis. Apoptosis is characterized by alterations in mitochondria and the endoplasmic reticulum and activation of cysteine proteases called caspases. Increasing evidence suggests that apoptotic biochemical cascades are involved in the dysfunction and death of neurons in neurodegenerative disorders such as Alzheimer's, Parkinson, and Huntington's diseases. Studies of normal aging, of genetic mutations that cause disease, and of environmental factors that affect disease risk are revealing cellular and molecular alterations that may cause excessive oxidative stress and trigger neuronal apoptosis. Accumulation of self-aggregating proteins such as amyloid beta-peptide, tau, alpha-synuclein, and huntingtin may be involved in apoptosis both upstream and downstream of oxidative stress. Membrane-associated oxidative stress resulting in perturbed lipid metabolism and disruption of cellular calcium homeostasis may trigger apoptosis in several different neurodegenerative disorders. Counteracting neurodegenerative processes are an array of mechanisms including neurotrophic factor signaling, antioxidant enzymes, protein chaperones, antiapoptotic proteins, and ionostatic systems. Emerging findings suggest that the resistance of neurons to death during aging can be enhanced by modifications of diet and lifestyle.
引用
收藏
页码:1997 / 2006
页数:10
相关论文
共 150 条
[1]  
ALEXIANU ME, 1994, J NEUROCHEM, V63, P2365
[2]   Neuroprotection by BDNF against glutamate-induced apoptotic cell death is mediated by ERK and PI3-kinase pathways [J].
Almeida, RD ;
Manadas, BJ ;
Melo, CV ;
Gomes, JR ;
Mendes, CS ;
Graos, MM ;
Carvalho, RF ;
Carvalho, AP ;
Duarte, CB .
CELL DEATH AND DIFFERENTIATION, 2005, 12 (10) :1329-1343
[3]   GLUTAMATE-INDUCED NEURONAL DEATH - A SUCCESSION OF NECROSIS OR APOPTOSIS DEPENDING ON MITOCHONDRIAL-FUNCTION [J].
ANKARCRONA, M ;
DYPBUKT, JM ;
BONFOCO, E ;
ZHIVOTOVSKY, B ;
ORRENIUS, S ;
LIPTON, SA ;
NICOTERA, P .
NEURON, 1995, 15 (04) :961-973
[4]   Intravenous basic fibroblast growth factor (bFGF) decreases DNA fragmentation and prevents downregulation of Bcl-2 expression in the ischemic brain following middle cerebral artery occlusion in rats [J].
Ay, I ;
Sugimori, H ;
Finklestein, SP .
MOLECULAR BRAIN RESEARCH, 2001, 87 (01) :71-80
[5]   p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease [J].
Bae, BI ;
Xu, H ;
Igarashi, S ;
Fujimuro, M ;
Agrawal, N ;
Taya, Y ;
Hayward, SD ;
Moran, TH ;
Montell, C ;
Ross, CA ;
Snyder, SH ;
Sawa, A .
NEURON, 2005, 47 (01) :29-41
[6]   Molecular mechanisms of selective dopaminergic neuronal death in Parkinson's disease [J].
Barzilai, A ;
Melamed, E .
TRENDS IN MOLECULAR MEDICINE, 2003, 9 (03) :126-132
[7]   Lessons from models of SOD1-linked familial ALS [J].
Bendotti, C ;
Carrì, MT .
TRENDS IN MOLECULAR MEDICINE, 2004, 10 (08) :393-400
[8]   Brain-derived neurotrophic factor mediates the anti-apoptotic effect of NMDA in cerebellar granule neurons: Signal transduction cascades and site of ethanol action [J].
Bhave, SV ;
Ghoda, L ;
Hoffman, PL .
JOURNAL OF NEUROSCIENCE, 1999, 19 (09) :3277-3286
[9]   Cytochrome c binds to inositol (1,4,5) trisphosphate receptors, amplifying calcium-dependent apoptosis [J].
Boehning, D ;
Patterson, RL ;
Sedaghat, L ;
Glebova, NO ;
Kurosaki, T ;
Snyder, SH .
NATURE CELL BIOLOGY, 2003, 5 (12) :1051-1061
[10]   3-nitropropionic acid animal model and Huntington's disease [J].
Borlongan, CV ;
Koutouzis, TK ;
Sanberg, PR .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1997, 21 (03) :289-293